NASDAQ:BTAI | Income Statement | BioXcel Therapeutics, Inc.

Complete source-backed income-statement history.

Available history
2017-03-31 to 2026-06-30
Data captured

Historical Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares
2026-06-30$182,000.00$22,000.00$3.16M$7.19M-$10.19M-$14.71M-$0.49-$0.4930,300,00030,300,000
2026-03-31$206,000.00$283,000.00$2.96M$7.19M-$10.22M-$12.69M-$0.54-$0.5423,571,00023,571,000
2025-12-31$256,000.00$32,000.00$6.7M$3.81M-$10.28M-$12.55M$0.65$0.653,216,0003,216,000
2025-09-30$98,000.00$11,000.00$8.74M$5.38M-$14.23M-$30.91M-$2.18-$2.1814,196,00014,196,000
2025-06-30$120,000.00$107,000.00$10.26M$5.61M-$15.85M-$19.19M-$2.45-$2.457,843,0007,843,000
2025-03-31$168,000.00$14,000.00$4.55M$5.7M-$10.1M-$7.25M-$1.50-$1.504,834,0004,834,000
2024-12-31$366,000.00$832,000.00$5.9M$4.09M-$10.49M-$10.86M-$2.91-$2.91169,000169,000
2024-09-30$214,000.00$1.17M$5.1M$7.68M-$15.29M-$13.65M-$5.15-$5.152,649,0002,649,000
2024-06-30$1.1M$62,000.00$8.03M$9.45M-$17.3M-$8.3M-$3.30-$3.302,516,0002,516,000
2024-03-31$582,000.00$80,000.00$11.4M$13.26M-$24.16M-$26.79M-$13.89-$13.891,929,0001,929,000
2023-12-31$376,000.00$714,000.00$9.93M$9.6M-$19.88M-$22.26M-$92.93-$92.93-27,205,000-27,205,000
2023-09-30$341,000.00$512,000.00$19.62M$24.34M-$48.3M-$50.49M-$1.72-$1.7229,268,00029,268,000
2023-06-30$457,000.00$26,000.00$26.97M$25.87M-$52.41M-$53.52M-$1.83-$1.8329,187,00029,187,000
2023-03-31$206,000.00$9,000.00$27.8M$23.6M-$51.2M-$52.8M-$1.84-$1.8428,616,00028,616,000
2022-12-31$238,000.00$9,000.00$32.46M$20.66M-$52.89M-$54.81M-$1.96-$1.9618,00018,000
2022-09-30$137,000.00$11,000.00$22.06M$17.05M-$38.99M$62,000.00-$41.81M-$1.49-$1.4928,022,00028,022,000
2022-06-30$17.91M$18.38M$36.29M-$36.29M-$37.67M-$1.35-$1.3527,989,00027,989,000
2022-03-31$18.56M$12.92M$31.48M-$31.48M-$31.47M-$1.12-$1.1227,980,00027,980
2021-12-31$12.53M$13.61M$26.13M-$26.13M-$26.13M-$0.92-$0.92541,000541,000
2021-09-30$11.93M$14.88M$26.81M-$26.81M-$26.81M-$0.96-$0.9627,972,00027,972,000
2021-06-30$13.51M$14.1M$27.61M-$27.61M-$27.62M-$1.11-$1.1124,962,00024,962,000
2021-03-31$14.74M$26.38M-$26.38M-$26.38M-$1.08-$1.0824,524,00024,524,000
2020-12-31$11.4M$21.1M-$21.1M-$21.09M904,000
2020-09-30$16.32M$24.77M-$24.77M-$24.75M23,050,000
2020-06-30$17.91M$21.44M-$21.44M-$21.42M20,293,000
2020-03-31$12.37M$15M-$15M-$14.91M18,968,000
2019-12-31$6.5M$8.41M-$8.41M-$8.28M593,737
2019-09-30$7.12M$9.13M-$9.13M-$9.02M15,752,196
2019-06-30$6.51M$8.64M-$8.64M-$8.47M15,668,588
2019-03-31$5.67M$7.42M-$7.42M-$7.2M15,663,795
2018-12-31$6.02M$7.31M-$7.31M-$7.08M343,361
2018-09-30$0.00$3.82M$5.12M-$5.12M-$4.89M15,645,545
2018-06-30$0.00$1.78M$3.24M-$3.24M-$3.03M15,645,545
2018-03-31$0.00$2.94M$4.29M-$4.29M-$4.28M11,456,325
2017-12-31$1.43M$2.53M-$2.53M-$2.53M201,687
2017-09-30$0.00$619,000.00$917,000.00-$917,000.00-$917,000.009,483,318
2017-06-30$0.00$324,000.00$565,000.00-$565,000.00-$565,000.009,480,000
2017-03-31$0.00$321,000.00-$529,000.00-$529,000.009,480,000

Annual Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares
2025-12-31$642,000.00$164,000.00$30.25M$20.49M-$50.46M$0.00-$69.9M-$5.73-$5.7312,208,00012,208,000
2024-12-31$2.27M$2.14M$30.44M$34.49M-$67.25M$0.00-$59.6M-$23.51-$23.512,535,0002,535,000
2023-12-31$1.38M$1.26M$84.33M$83.41M-$171.78M$0.00-$179.05M-$98.33-$98.331,821,0001,821,000
2022-12-31$375,000.00$20,000.00$91.24M$68.76M-$159.65M-$165.76M-$5.92-$5.9228,015,00028,015,000
2021-12-31$52.71M$54.23M$106.94M-$106.94M-$106.93M-$4.05-$4.0526,373,00026,373,000
2020-12-31$58M$82.3M-$82.3M-$82.17M-$3.79-$3.7921,683,00021,683,000
2019-12-31$25.8M$33.6M-$33.6M-$32.97M16,289,000
2018-12-31$14.56M$19.96M-$19.96M-$19.27M14,571,553
2017-12-31$2.69M$4.54M-$4.54M-$4.54M9,685,005